Search arXiv papers, download full text, semantic search, citation graphs, and alerts via MCP.
Nothing to run from here
AgingResearch.News is installed from its publisher's own source and answers where it runs, so this marketplace is not in the path of a single call. There is no address here to send one to, and a panel that pretended otherwise would be showing you an answer we made up. Install it and call it from your own client — the Installation tab has the entry for each one.
26
tools declared
—
trust score
remote
at its publisher
—
calls last 7d
What it does
Search aging research papers, evidence, trials and grants; follow topics through Sign in with ARN.
Quickstart
# 1 — add it to Claude Code
claude mcp add --scope user --transport http agingresearch-news-mcp https://agingresearch.news/api/mcp
# 2 — ask your agent for something these tools do
# search_papers, list_papers, get_paper and 23 more
AgingResearch.News costs nothing on mcprush: there is no plan to choose here, no cap to set and nothing mcprush can bill you for.
Publishernot claimed
AGAll 1 server
agingresearch1 server
1 category
Collected from a public index. Nobody has claimed this account, so nothing here was written by its author — claim it if it is yours.
Installation
Where are you running it?
Every route below installs the same thing and ends at the same approval screen. Nothing here runs on your machine and nothing runs on ours: this server answers at its publisher’s own address, and what you install is the connection straight to it.
Claude Codedeclared by this listing
This is a public server: it answers at its publisher’s own address and this marketplace is not in the path. Claude Code registers it in one command; --scope user makes it available in every project. The transport below is http, as the publisher's own manifest declares it.
claude mcp add --scope user --transport http agingresearch-news-mcp https://agingresearch.news/api/mcpReconnect, or start a new session, and the tools appear in the model’s tool list.
Free on mcprush, and it answers at its publisher’s own address: this marketplace is not in the path, so there is no key of ours to hold and no card to add.
What it writes
One config entry pointing straight at the publisher’s own address — this marketplace is not in the path, and nothing from this listing executes on your machine.
What you approve
26 tools, with what each one reads, writes and reaches shown before you agree — the same list on every route above. Read the tool surface.
Tool surface
What the model actually sees. Descriptions are diffed on every release — see version history.
Use this when the user asks what research has found on a question in the biology of aging or an age-related disease, often without the word aging: senescence and senolytics, epigenetic clocks, partial reprogramming, mitochondrial dysfunction, NAD+, inflammaging and immune aging, ovarian aging and menopause, neurodegeneration, cardiovascular and metabolic decline, sarcopenia, regeneration, and long
| Parameter | Type | Required | Notes |
|---|---|---|---|
| q | string | yes | Search terms. Supports "quoted phrases", OR and -exclusions. |
| since | string | no | Only papers added on or after this UTC date (YYYY-MM-DD; a full ISO timestamp is cut to its date). |
| until | string | no | Only papers added on or before this UTC date (YYYY-MM-DD). |
| min_relevance | number | no | How closely papers must bear on aging, 0 to 3. Leave out for papers about aging; 1 adds adjacent papers; 0 returns every paper read, most of them not about aging. |
| study_type | array | no | Main source of evidence. |
| category | array | no | Category slug. A paper matches when its category or its secondary category is listed. |
| system | array | no | Body system key (see systems). A paper matches when it involves any of them. |
| age_link | array | no | How the work itself connects to aging. |
| preprint | boolean | no | true for preprints only, false for peer-reviewed papers only. Omit for both. |
| author | string | no | Papers by an author. A name matches every author who answers to it: the words in any order, with or without accents, an initial standing for any name it begins (sinclair d). An author_id from a pa |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks what is new: the latest papers in a field (mitochondrial dysfunction, immune aging, senolytics), of a study type such as randomised trials, on a body system, or by one author (author takes a name, or an author_id from get_paper), for example to shortlist a lab's journal club. Lists the newest papers AgingResearch.News has read, by the date they were added, with the same
| Parameter | Type | Required | Notes |
|---|---|---|---|
| since | string | no | Only papers added on or after this UTC date (YYYY-MM-DD; a full ISO timestamp is cut to its date). |
| until | string | no | Only papers added on or before this UTC date (YYYY-MM-DD). |
| min_relevance | number | no | How closely papers must bear on aging, 0 to 3. Leave out for papers about aging; 1 adds adjacent papers; 0 returns every paper read, most of them not about aging. |
| study_type | array | no | Main source of evidence. |
| category | array | no | Category slug. A paper matches when its category or its secondary category is listed. |
| system | array | no | Body system key (see systems). A paper matches when it involves any of them. |
| age_link | array | no | How the work itself connects to aging. |
| preprint | boolean | no | true for preprints only, false for peer-reviewed papers only. Omit for both. |
| author | string | no | Papers by an author. A name matches every author who answers to it: the words in any order, with or without accents, an initial standing for any name it begins (sinclair d). An author_id from a pa |
| q | string | no | Full-text filter over title and abstract. Supports "quoted phrases", OR and -exclusions. Results stay in date order; use search_papers for ranked results. |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user wants one paper in depth: what it did and found, in which species and how many subjects, its caveats, who wrote it and where they work. Takes a paper id such as MED-42823970 from another tool's results. Returns how it bears on aging, the language it was published in with its own-language title when that is not English, every author with ORCID iD and institutions, its full st
| Parameter | Type | Required | Notes |
|---|---|---|---|
| id | string | yes | Paper id, e.g. MED-42823970. |
Use this when the user wants a readable round-up of recent findings: what happened this week in aging research, the notable results in a field, or a short list for a journal club. Lists the stories AgingResearch.News wrote about new papers, newest first, each checked against its paper: a plain-language headline, body, why it matters and caveats, with the paper. Narrow by category, body system, stu
| Parameter | Type | Required | Notes |
|---|---|---|---|
| since | string | no | Only stories published on or after this UTC date (YYYY-MM-DD). |
| until | string | no | Only stories published on or before this UTC date (YYYY-MM-DD). |
| category | array | no | Category slug. A paper matches when its category or its secondary category is listed. |
| system | array | no | Body system key (see systems). A paper matches when it involves any of them. |
| study_type | array | no | Main source of evidence. |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this to find the type and key of what a question names (a drug, supplement or diet, a gene or protein, a biological process, a disease, a biomarker, an organism, a method or a hallmark of aging) before get_entity, list_claims or list_grants. Matches part of a name, a key or a known synonym, case-insensitive, most-studied first, with how many papers involve each. Pass a result's type and key to
| Parameter | Type | Required | Notes |
|---|---|---|---|
| type | string | no | Entity type, e.g. intervention, gene, pathway, component, system, method, hallmark, phenotype, organism, tissue, disease, biomarker, mesh. |
| q | string | no | Match on name or key, case-insensitive substring. |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this for questions about one drug, supplement, gene, process or disease, such as: is there human evidence for this intervention; has the finding been replicated by independent labs; in which species; what trials test it and how many have posted no results; who funds the work and which companies are tied to it; what the newest papers on it report. Takes a type and key from find_entities (interv
| Parameter | Type | Required | Notes |
|---|---|---|---|
| type | string | yes | Entity type. |
| key | string | yes | Entity key within its type. |
| min_relevance | number | no | Lowest aging-relevance score for the papers listed. Default: no filter. |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks what has been found about a relation: does an intervention extend lifespan, and in which organisms; what lowers a biomarker; what acts on a process. Lists findings extracted from papers as subject, relation and object (for example rapamycin extends_lifespan in Mus musculus), with organism, conditions, effect size and the paper, newest first. Narrow by subject, object, r
| Parameter | Type | Required | Notes |
|---|---|---|---|
| subject | string | no | Subject text, entity name or entity key (case-insensitive substring). |
| object | string | no | Object text, entity name or entity key (case-insensitive substring). |
| relation | string | no | Exact relation, e.g. increases, decreases, associated_with, extends_lifespan. |
| organism | string | no | Organism, e.g. Homo sapiens, Mus musculus (case-insensitive substring). |
| paper_id | string | no | Only claims from this paper. |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks about clinical trials on aging or an age-related condition: what is recruiting, what changed lately (a new status, a completion, results posted), which trials test a drug, or which companies run them. Lists trials from ClinicalTrials.gov that bear on human aging, newest registry update first: phase, status, sponsor, size, conditions, interventions and the latest change.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| q | string | no | Words that must all appear in the trial's titles, conditions, interventions, keywords or sponsor (case-insensitive). |
| phase | array | no | Phase: 1 (early phase 1 and phase 1), 2, 3, 4, or none for studies with no phase. |
| status | array | no | Recruitment status: recruiting (recruiting, not yet recruiting or by invitation), active (active, not recruiting), completed, or stopped (terminated, withdrawn or suspended). |
| focus | array | no | The trial's main connection to aging (see focus). |
| industry | boolean | no | true for trials whose lead sponsor is a company, false for the rest. Omit for both. |
| since | string | no | Only trials the registry updated on or after this date (YYYY-MM-DD). |
| min_relevance | number | no | Lowest aging-relevance score to include (0 to 3, see relevance). Default 1.8, the trials about aging. |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks about one clinical trial by its registry number (NCT, ISRCTN, ChiCTR, CTRI, CTIS and the rest): its design, outcomes and dates, what changed and when, and which papers cite it. Returns the registry's summary, outcomes and dates, every change recorded and the papers that cite it. A record from the WHO ICTRP carries its attribution and the day WHO processed it, to show wi
| Parameter | Type | Required | Notes |
|---|---|---|---|
| nct_id | string | yes | The trial's registry number, e.g. NCT04488601 or ISRCTN12345678. |
Use this when the user asks about events in aging research and the longevity industry: company financings and deals, trial readouts, approvals and regulators, policy, conferences. One story per event, newest first, written by AgingResearch.News with a link to every outlet that covered it. Narrow by words, kind or date. Only news of this field; not for general, political or market news.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| q | string | no | Words that must all appear in the story's headline or summary (case-insensitive). |
| kind | string | no | Only stories of this kind. |
| since | string | no | Only stories with coverage on or after this UTC date (YYYY-MM-DD). |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks who funds work on a target, a drug, a process or a lab, how much and since when, or what a funder pays for in aging research. Lists research grants from NIH, the EU (CORDIS), UKRI and Wellcome that bear on aging, newest award first: title, funder, holder, investigators, amount, funded period, scheme and a link to the record. Narrow by an entity the title names (type:key
| Parameter | Type | Required | Notes |
|---|---|---|---|
| q | string | no | Words of the grant's title ("quoted phrases", OR and -exclusions work). |
| entity | string | no | Only grants whose titles name this entity, as type:key (see /entities), e.g. intervention:rapamycin or disease:sarcopenia. |
| funder | string | no | Only grants from this funder, by its organisation key or name, e.g. nia or wellcome. |
| holder | string | no | Only grants held by this organisation (its key) or investigator (person: and their key), e.g. buck-institute-for-research-on-aging. |
| since | string | no | Only grants awarded on or after this date (YYYY-MM-DD). |
| until | string | no | Only grants awarded on or before this date (YYYY-MM-DD). |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks which meetings on aging research and age-related disease are coming up, or which have just been held. The conference calendar: meetings still to come or on, soonest first, then recent ones, each edition with its dates, place and how many of its abstracts are held. Read one, and an edition's abstracts, with get_conference.
No parameter schema on file.
Use this when the user asks about one meeting from list_conferences, or what was presented there. Returns its organiser, site and every edition; with edition, that edition's abstracts worth reading, the most relevant first, each with its number, format and the paper it was later published as. An abstract is not a peer-reviewed paper. Read one in full with get_paper.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| id | string | yes | Conference id from list_conferences, e.g. gsa. |
| edition | string | no | An edition from editions, e.g. 2025: list its abstracts. |
| min_visibility | string | no | With edition: which abstracts to list, from the most to the least worth reading: core, visible, searchable, matchable, out. Default visible, those worth reading. |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks which drugs or therapies are in development against a target, a mechanism, a hallmark of aging or an age-related disease, who develops them and how far each has got. Lists drug and therapy programmes (assets), furthest stage first: each with its developers and partners, code names, modality, targets, mechanism, indications with the stage of each, hallmarks of aging and
| Parameter | Type | Required | Notes |
|---|---|---|---|
| target | string | no | A target: a gene symbol or key (GLP1R, bcl2l1) or a process key (mtor, cellular-senescence). |
| mechanism | string | no | Words that must all appear in the asset's mechanism line (case-insensitive). |
| modality | string | no | The kind of therapy (see modality). |
| hallmark | string | no | A hallmark of aging the asset acts on. |
| indication | string | no | A disease, by name or entity key (idiopathic pulmonary fibrosis, alzheimer-disease). |
| stage | string | no | Stage: with indication, the stage for that indication; otherwise the asset's furthest stage. |
| country | string | no | The developer's country, ISO 3166 alpha-2 (US, GB, CH). |
| organisation | string | no | An organisation key: the assets it develops, partners on or licensed out. |
| q | string | no | Letters and digits in any of the asset's names or code names (UBX1325 matches UBX-1325). |
| cursor | string | no | Opaque cursor from pagination.next_cursor of the previous page. Keep the other parameters the same. |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks about one drug or therapy programme by its name or any code name (ubx1325, UBX-1325, BMS-986278). Returns its developers, partners and licensors, targets, mechanism, modality, every indication with its stage and the trial or source behind it, its lifespan evidence and the news that names it. An account whose plan includes drug and therapy programmes reads every record i
| Parameter | Type | Required | Notes |
|---|---|---|---|
| key | string | yes | The asset's key or a code name. |
Use this when the user asks how many drug and therapy programmes there are, or how a field's pipeline splits. Counts programmes grouped by stage, modality, target, hallmark, indication, the developer's country or the developer, with each group's count at each stage. Takes list_assets' filters: by=target with indication=obesity counts the targets of obesity programmes. An account whose plan include
| Parameter | Type | Required | Notes |
|---|---|---|---|
| by | string | no | What to group by. |
| target | string | no | A target: a gene symbol or key (GLP1R, bcl2l1) or a process key (mtor, cellular-senescence). |
| mechanism | string | no | Words that must all appear in the asset's mechanism line (case-insensitive). |
| modality | string | no | The kind of therapy (see modality). |
| hallmark | string | no | A hallmark of aging the asset acts on. |
| indication | string | no | A disease, by name or entity key (idiopathic pulmonary fibrosis, alzheimer-disease). |
| stage | string | no | Stage: with indication, the stage for that indication; otherwise the asset's furthest stage. |
| country | string | no | The developer's country, ISO 3166 alpha-2 (US, GB, CH). |
| organisation | string | no | An organisation key: the assets it develops, partners on or licensed out. |
| q | string | no | Letters and digits in any of the asset's names or code names (UBX1325 matches UBX-1325). |
| limit | integer | no | Results per page, 1 to 25. |
Use this when the user asks to follow a drug, gene, process, disease or other entity on AgingResearch.News, so its new papers reach them. Takes the type and key that find_entities or get_entity give. Following is saved to the user's account: new papers on it appear in For you and the daily follow email.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| type | string | yes | The entity's type, as find_entities or get_entity gives it. |
| key | string | yes | The entity's key within its type, such as rapamycin. |
Use this when the user asks to stop following a drug, gene, process or other entity on AgingResearch.News. Takes the type and key that list_follows, find_entities or get_entity give. Removes the follow from the user's account.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| type | string | yes | The entity's type, as find_entities or get_entity gives it. |
| key | string | yes | The entity's key within its type, such as rapamycin. |
Use this when the user asks what they follow on AgingResearch.News. Lists the drugs, genes, processes and saved searches their account follows, newest first, each with its page; an entity's id is the type:key that unfollow takes.
No parameter schema on file.
Use this when the user asks about questions they asked AgingResearch.News (Ask) before. Lists their most recent conversations, newest first, each with its title and its address, where the answer and its sources are.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| limit | integer | no | How many, 1 to 25. |
Use this when the user asks to open AgingResearch.News or to see their feed, follows and recent questions in one place. Shows the newest stories (For you when the user is signed in, else Top), what they follow and their recent questions, with search.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| tab | string | no | Which feed to open on. |
The sidebar's feed: For you or Top, as story cards.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| tab | string | no | — |
The sidebar's search: topics and papers matching words, as cards.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| q | string | yes | — |
Use this when the user asks a research question on the biology of aging, longevity interventions, age-related disease, or the people and companies of the field (for example: does rapamycin extend lifespan in people, what is known about senolytics for frailty, who works on epigenetic clocks). Not for personal medical advice, doses or symptoms. It answers from AgingResearch.News's own record of pape
| Parameter | Type | Required | Notes |
|---|---|---|---|
| question | string | yes | The research question in the user's words, in any language; the answer is written in the question's language. |
| conversation_id | string | no | To ask a follow-up in a conversation this tool or ask_arn started: its conversation.id. Leave out to start a new conversation. |
Use this when the user asks for a full review of the evidence on a research question in aging or longevity, beyond a short answer. Not for personal medical advice, doses or symptoms. It writes, over several minutes, a review in five sections: the bottom line, the evidence by kind of study, contradictions and gaps, how far it has got toward patients, and what would change the answer. It is started
| Parameter | Type | Required | Notes |
|---|---|---|---|
| question | string | yes | The research question in the user's words, in any language; the answer is written in the question's language. |
| conversation_id | string | no | To ask a follow-up in a conversation this tool or ask_arn started: its conversation.id. Leave out to start a new conversation. |
Use this when ask_arn or start_ultradeep said an answer is still being written, or the user wants it again: it reads that question's answer by the question_id they gave: the answer with its numbered sources once it is written, or where it stands while it is written. Waits up to 20 seconds for a short answer that is nearly done; an Ultradeep review takes several minutes.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| question_id | integer | yes | The question_id ask_arn or start_ultradeep gave. |
Free
$0 forever
- Every tool — any call limit is its publisher’s, not ours
- No card, and mcprush charges nothing for it
- Runs at its publisher’s own address — this marketplace is not in the path
- Nothing to cap, because mcprush bills nothing
What counts against your monthly calls
| Tool | Unit | Calls used | Out of the allowance |
|---|
Nothing here is billable: mcprush charges nothing to install AgingResearch.News or to call it, at any volume.
Call allowance · this installenforced at the gateway
Monthly allowance, in calls
—
—
Alert at 80% · then the tool returns a normal MCP error
Used this month: —
—Grade not published
No rule-by-rule report on file for this release
Two independent axes, because powerful and malicious are different questions. The grade is threat only. The capability level is blast radius, and it is never a penalty on the grade — it is priced as one subtract-only term in the score, where you can see it.
This listing is an address its publisher runs, and you connect to it directly — this marketplace is not in the path. The scanner reads packages and public source, and an address is neither. So there is no grade — not a withheld one, an unmeasured one.
Release history
This is an address its publisher runs: which release it serves is theirs to choose, so there is nothing here to pin. The history below is for reading; the current release on file is 1.3.0.
1.3.0
undated
latestNo release note was published with this version.
—
no reviews yet
Who can review
One review per account, from a signed-in account that does not publish this listing. Nothing else is asked — you can say what you think before you install it. Publishers can reply once per review, and a review can be edited or deleted by whoever wrote it.
Sign in to write one
Any signed-in account that does not publish AgingResearch.News can review it, once — before installing it or after. A review from an account that has installed it is marked as one.
No reviews yet
Nobody has reviewed this listing. The rating on the card is the mean of the reviews written here and nothing else, so there is no rating until somebody writes the first — which takes a signed-in account that does not publish it, and nothing else.